
Investors who subscribed to the ₹475.48 crore Sahajanand Medical Technologies IPO can expect the share allotment to be finalised on October 19, 2026. The allotment details can be accessed online through the NSE and BSE websites or via the IPO registrar, MUFG Intime India Private Limited.
Once the allotment is concluded, Sahajanand Medical Technologies is scheduled to make its stock market debut on October 23, 2026, on both the NSE and BSE.
Explore other Upcoming IPOs on BSE and NSE.
[October 19, 2026, 7:00 P.M.]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
34.70x |
|
Non-Institutional Investors (NIIs) |
14.64x |
|
Retail Individual Investors (RIIs) |
3.03x |
|
Employees |
0.37x |
|
Total |
14.20x |
Established in 2001, Sahajanand Medical Technologies specialises in the development and manufacture of medical devices, supported by a focus on research and development. Its portfolio includes products for vascular and structural heart procedures, such as coronary stents and balloons, transcatheter aortic valve implantation (TAVI) devices, occluders, renal stents and peripheral drug-coated balloons (DCBs).
In FY2026, the company’s products reached 77 countries. During the three months ended June 30, 2026, it distributed its products across 65 countries, including India.
|
Particulars |
For the three month period ended June 30, 2026 (in ₹ crore) |
FY26 (in ₹ crore) |
FY25 (in ₹ crore) |
|
Revenue from operations |
351.67 |
1,210.50 |
1,024.88 |
|
EBITDA |
48.58 |
170.65 |
128.02 |
|
Profit After Tax (PAT) |
15.09 |
69.08 |
25.15 |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here